Comp Blood Analysis Sample Report

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5
At a glance
Powered by AI
The patient report provides results from a variety of medical tests performed on the patient.

Tests performed included a CBC, metabolic panel, lipid panel, thyroid panel, and various vitamin and mineral levels.

The metabolic panel showed elevated glucose and albumin levels, and normal results for other components like BUN and creatinine.

1 Patient Report

Specimen ID: 289-059-8991-0 Acct #: 12502800 Phone: (847) 222-9546 Rte: 31


Control ID: B0095212223
DHA Laboratory
HILNER, KEN 411 E. Business Center Dr Ste 107
10200 BIG CANOE Mount Prospect IL 60056
BIG CANOE GA 30143
(678) 232-2574

Patient Details Specimen Details Physician Details


DOB: 07/21/1946 Date collected: 10/16/2019 1303 Local Ordering: D JOCKERS
Age(y/m/d): 073/02/25 Date received: 10/16/2019 Referring:
Gender: M SSN: Date entered: 10/16/2019 ID: 14430073
Patient ID: 33626DRJ Date reported: 10/20/2019 1606 ET NPI: 1003051327
General Comments & Additional Information
Clinical Info: DO NOT BILL PATIENT. BIL
Clinical Info: L ACCOUNT 125
Alternate Control Number: B0095212223 Alternate Patient ID: Not Provided
Total Volume: Not Provided Fasting: Yes
Ordered Items
CBC With Differential/Platelet; Comp. Metabolic Panel (14); Urinalysis, Routine; Lipid Panel w/ Chol/HDL Ratio; Thyroid Panel With
TSH; Iron and TIBC; Hemoglobin A1c; Thyroxine (T4) Free, Direct, S; Folate (Folic Acid), Serum; Testosterone, Serum; Plasma Zinc;
Vitamin A, Serum; Reverse T3, Serum; Calcitriol(1,25 di-OH Vit D); Vitamin D, 25-Hydroxy; Fructosamine; Lipoprotein (a); C-Reactive
Protein, Cardiac; Homocyst(e)ine; Uric Acid; LDH; GGT; Triiodothyronine (T3); Sedimentation Rate-Westergren; Thyroglobulin Antibody;
Vitamin B12; Magnesium; Copper, Serum; Fibrinogen Activity; Insulin; Ferritin, Serum; Thyroid Peroxidase (TPO) Ab; Triiodothyronine
(T3), Free; PTH, Intact; Venipuncture
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
CBC With Differential/Platelet
WBC 6.5 x10E3/uL 3.4 - 10.8 01
RBC 4.55 x10E6/uL 4.14 - 5.80 01
Hemoglobin 14.7 g/dL 13.0 - 17.7 01
Hematocrit 44.3 % 37.5 - 51.0 01
MCV 97 fL 79 - 97 01
MCH 32.3 pg 26.6 - 33.0 01
MCHC 33.2 g/dL 31.5 - 35.7 01
RDW 13.6 % 12.3 - 15.4 01
Platelets 297 x10E3/uL 150 - 450 01
Neutrophils 67 % Not Estab. 01
Lymphs 25 % Not Estab. 01
Monocytes 6 % Not Estab. 01
Eos 2 % Not Estab. 01
Basos 0 % Not Estab. 01
Neutrophils (Absolute) 4.4 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 1.6 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.4 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.2 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % Not Estab. 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01

Comp. Metabolic Panel (14)

Date Issued: 10/20/19 1606 ET FINAL REPORT Page 1 of 5


This document contains private and confidential health information protected by state and federal law. 1995-2019 Laboratory Corporation of America Holdings
If you have received this document in error, please call 205-581-3500 All Rights Reserved - Enterprise Report Version: 1.00
1 Patient Report
Patient: HILNER, KEN Specimen ID: 289-059-8991-0
DOB: 07/21/1946 Patient ID: 33626DRJ Control ID: B0095212223 Date collected: 10/16/2019 1303 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB


Glucose 116 High mg/dL 65 - 99 01
BUN 19 mg/dL 8 - 27 01
Creatinine 1.05 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 70 mL/min/1.73 >59
eGFR If Africn Am 81 mL/min/1.73 >59
BUN/Creatinine Ratio 18 10 - 24
Sodium 144 mmol/L 134 - 144 01
Potassium 4.8 mmol/L 3.5 - 5.2 01
Chloride 103 mmol/L 96 - 106 01
Carbon Dioxide, Total 28 mmol/L 20 - 29 01
Calcium 10.1 mg/dL 8.6 - 10.2 01
Protein, Total 7.2 g/dL 6.0 - 8.5 01
Albumin 5.2 High g/dL 3.5 - 4.8 01
Globulin, Total 2.0 g/dL 1.5 - 4.5
A/G Ratio 2.6 High 1.2 - 2.2
Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase 56 IU/L 39 - 117 01
AST (SGOT) 20 IU/L 0 - 40 01
ALT (SGPT) 6 IU/L 0 - 44 01

Urinalysis, Routine
Urinalysis Gross Exam 01
Specific Gravity 1.027 1.005 - 1.030 01
pH 5.0 5.0 - 7.5 01
Urine-Color Yellow Yellow 01
Appearance Clear Clear 01
WBC Esterase Negative Negative 01
Protein Negative Negative/Trace 01
Glucose Negative Negative 01
Ketones Negative Negative 01
Occult Blood Negative Negative 01
Bilirubin Negative Negative 01
Urobilinogen,Semi-Qn 0.2 mg/dL 0.2 - 1.0 01
Nitrite, Urine Negative Negative 01
Microscopic Examination 01
Microscopic not indicated and not performed.

Lipid Panel w/ Chol/HDL Ratio


Cholesterol, Total 239 High mg/dL 100 - 199 01
Triglycerides 44 mg/dL 0 - 149 01
HDL Cholesterol 85 mg/dL >39 01
VLDL Cholesterol Cal 9 mg/dL 5 - 40
LDL Cholesterol Calc 145 High mg/dL 0 - 99

Date Issued: 10/20/19 1606 ET FINAL REPORT Page 2 of 5


This document contains private and confidential health information protected by state and federal law. 1995-2019 Laboratory Corporation of America Holdings
If you have received this document in error, please call 205-581-3500 All Rights Reserved - Enterprise Report Version: 1.00
1 Patient Report
Patient: HILNER, KEN Specimen ID: 289-059-8991-0
DOB: 07/21/1946 Patient ID: 33626DRJ Control ID: B0095212223 Date collected: 10/16/2019 1303 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB


T. Chol/HDL Ratio 2.8 ratio 0.0 - 5.0
Please Note: 01
T. Chol/HDL Ratio
Men Women
1/2 Avg.Risk 3.4 3.3
Avg.Risk 5.0 4.4
2X Avg.Risk 9.6 7.1
3X Avg.Risk 23.4 11.0

Thyroid Panel With TSH


TSH 1.640 uIU/mL 0.450 - 4.500 01
Thyroxine (T4) 6.4 ug/dL 4.5 - 12.0 01
T3 Uptake 27 % 24 - 39 01
Free Thyroxine Index 1.7 1.2 - 4.9

Iron and TIBC


Iron Bind.Cap.(TIBC) 457 High ug/dL 250 - 450
UIBC 298 ug/dL 111 - 343 01
Iron 159 ug/dL 38 - 169 01
Iron Saturation 35 % 15 - 55

Hemoglobin A1c
Hemoglobin A1c 5.9 High % 4.8 - 5.6 01
Please Note: 01
Prediabetes: 5.7 - 6.4
Diabetes: >6.4
Glycemic control for adults with diabetes: <7.0

Thyroxine (T4) Free, Direct, S


T4,Free(Direct) 1.27 ng/dL 0.82 - 1.77 01

Folate (Folic Acid), Serum


Folate (Folic Acid), Serum >20.0 ng/mL >3.0 01
Note: 01
A serum folate concentration of less than 3.1 ng/mL is
considered to represent clinical deficiency.

Testosterone, Serum 601 ng/dL 264 - 916 01


Adult male reference interval is based on a population of
healthy nonobese males (BMI <30) between 19 and 39 years old.
Travison, et.al. JCEM 2017,102;1161-1173. PMID: 28324103.

Plasma Zinc 115 ug/dL 56 - 134 02


Detection Limit = 5

Vitamin A, Serum
Vitamin A 69.9 High ug/dL 22.0 - 69.5 02
Reference intervals for vitamin A determined from LabCorp internal

Date Issued: 10/20/19 1606 ET FINAL REPORT Page 3 of 5


This document contains private and confidential health information protected by state and federal law. 1995-2019 Laboratory Corporation of America Holdings
If you have received this document in error, please call 205-581-3500 All Rights Reserved - Enterprise Report Version: 1.00
1 Patient Report
Patient: HILNER, KEN Specimen ID: 289-059-8991-0
DOB: 07/21/1946 Patient ID: 33626DRJ Control ID: B0095212223 Date collected: 10/16/2019 1303 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB


studies. Individuals with vitamin A less than 20 ug/dL are considered
vitamin A deficient and those with serum concentrations less than
10 ug/dL are considered severely deficient.
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared or approved
by the Food and Drug Administration.
A
Reverse T3, Serum 13.7 ng/dL 9.2 - 24.1 02

Calcitriol(1,25 di-OH Vit D) 55.5 pg/mL 19.9 - 79.3 02

Vitamin D, 25-Hydroxy 63.1 ng/mL 30.0 - 100.0 01


Vitamin D deficiency has been defined by the Institute of
Medicine and an Endocrine Society practice guideline as a
level of serum 25-OH vitamin D less than 20 ng/mL (1,2).
The Endocrine Society went on to further define vitamin D
insufficiency as a level between 21 and 29 ng/mL (2).
1. IOM (Institute of Medicine). 2010. Dietary reference
intakes for calcium and D. Washington DC: The
National Academies Press.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.
Evaluation, treatment, and prevention of vitamin D
deficiency: an Endocrine Society clinical practice
guideline. JCEM. 2011 Jul; 96(7):1911-30.

Fructosamine 346 High umol/L 0 - 285 01


Published reference interval for apparently healthy subjects
between age 20 and 60 is 205 - 285 umol/L and in a poorly
controlled diabetic population is 228 - 563 umol/L with a
mean of 396 umol/L.

Lipoprotein (a) 17.4 nmol/L <75.0 02


Note: Values greater than or equal to 75.0 nmol/L may
indicate an independent risk factor for CHD,
but must be evaluated with caution when applied
to non-Caucasian populations due to the
influence of genetic factors on Lp(a) across
ethnicities.

C-Reactive Protein, Cardiac <0.15 mg/L 0.00 - 3.00 01


Relative Risk for Future Cardiovascular Event
Low <1.00
Average 1.00 - 3.00
High >3.00

Homocyst(e)ine 13.0 umol/L 0.0 - 15.0 01

Uric Acid
Uric Acid 3.9 mg/dL 3.7 - 8.6 01
Please Note: 01
Therapeutic target for gout patients: <6.0
Date Issued: 10/20/19 1606 ET FINAL REPORT Page 4 of 5
This document contains private and confidential health information protected by state and federal law. 1995-2019 Laboratory Corporation of America Holdings
If you have received this document in error, please call 205-581-3500 All Rights Reserved - Enterprise Report Version: 1.00
1 Patient Report
Patient: HILNER, KEN Specimen ID: 289-059-8991-0
DOB: 07/21/1946 Patient ID: 33626DRJ Control ID: B0095212223 Date collected: 10/16/2019 1303 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB

LDH 167 IU/L 121 - 224 01

GGT 15 IU/L 0 - 65 01

Triiodothyronine (T3) 96 ng/dL 71 - 180 01

Sedimentation Rate-Westergren
2 mm/hr 0 - 30 01

Thyroglobulin Antibody <1.0 IU/mL 0.0 - 0.9 01


Thyroglobulin Antibody measured by Beckman Coulter Methodology

Vitamin B12 1200 pg/mL 232 - 1245 01

Magnesium 2.3 mg/dL 1.6 - 2.3 01


B
Copper, Serum 64 Low ug/dL 72 - 166 02
Detection Limit = 5

Fibrinogen Activity 234 mg/dL 193 - 507 01

Insulin 5.8 uIU/mL 2.6 - 24.9 01

Ferritin, Serum 90 ng/mL 30 - 400 01

Thyroid Peroxidase (TPO) Ab 23 IU/mL 0 - 34 01

Triiodothyronine (T3), Free 3.1 pg/mL 2.0 - 4.4 01

PTH, Intact 42 pg/mL 15 - 65 01

Comments:
A This test was developed and its performance characteristics determined by
LabCorp. It has not been cleared or approved by the Food and Drug
Administration.
B This test was developed and its performance characteristics determined by
LabCorp. It has not been cleared or approved by the Food and Drug
Administration.

01 MB LabCorp Birmingham Dir: Brian Ragland, MD


1801 First Avenue South, Birmingham, AL 35233-1935
02 BN LabCorp Burlington Dir: Sanjai Nagendra, MD
1447 York Court, Burlington, NC 27215-3361
For inquiries, the physician may contact Branch: 800-597-8026 Lab: 205-581-3500

Date Issued: 10/20/19 1606 ET FINAL REPORT Page 5 of 5


This document contains private and confidential health information protected by state and federal law. 1995-2019 Laboratory Corporation of America Holdings
If you have received this document in error, please call 205-581-3500 All Rights Reserved - Enterprise Report Version: 1.00

You might also like